TSE:APS

Aptose Biosciences (APS) Stock Forecast, Price & News

C$0.58

+0.05 (+9.43%)

(As of 06/2/2023 ET)

Compare

Today's Range: C$0.58
▼
C$0.58
50-Day Range: C$0.53
▼
C$0.90
52-Week Range: C$0.51
▼
C$1.28

Volume: 5,700 shs
Average Volume: 18,795 shs
Market Capitalization: C$54.32 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: C$5.00

Profile Analyst Ratings Chart Competitors Earnings Insider Trades Headlines Social Media

About Aptose Biosciences (TSE:APS) Stock

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.

Receive APS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter.

APS Stock News Headlines

May 31, 2023 | finance.yahoo.com

Aptose to Hold Interim Clinical Update Webcast on Saturday, June 10, 2023

May 26, 2023 | seekingalpha.com

Aptose to sell up to $25M stock in the U.S.

June 3, 2023 | Legacy Research (Affiliate) (Ad)

“Amazon Loophole” could hand you $28,544 in “royalty” payouts

Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.

May 17, 2023 | theglobeandmail.com

Closing Bell: Aptose Biosciences Inc flat on Tuesday (APS)

May 14, 2023 | americanbankingnews.com

FY2023 Earnings Estimate for Aptose Biosciences Inc. Issued By Cantor Fitzgerald (TSE:APS)

May 12, 2023 | americanbankingnews.com

Aptose Biosciences Inc. (TSE:APS) to Post Q2 2023 Earnings of ($0.20) Per Share, HC Wainwright Forecasts

May 11, 2023 | finance.yahoo.com

Aptose Biosciences Inc.'s (TSE:APS) Path To Profitability

May 11, 2023 | americanbankingnews.com

Aptose Biosciences (TSE:APS) Issues Earnings Results

June 3, 2023 | Stocks To Trade (Ad)

15 A.I. Trading Opportunities a Day

Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.

May 10, 2023 | theglobeandmail.com

Closing Bell: Aptose Biosciences Inc down on Wednesday (APS)

May 8, 2023 | finance.yahoo.com

Aptose Reports Results for the First Quarter 2023

May 4, 2023 | finance.yahoo.com

Aptose to Participate in RBC Capital Markets 2023 Global Healthcare Conference

May 2, 2023 | theglobeandmail.com

Closing Bell: Aptose Biosciences Inc up on Monday (APS)

May 1, 2023 | americanbankingnews.com

Aptose Biosciences (APS) to Release Quarterly Earnings on Monday

April 1, 2023 | americanbankingnews.com

Aptose Biosciences Inc. to Post Q1 2023 Earnings of ($0.16) Per Share, Oppenheimer Forecasts (TSE:APS)

March 31, 2023 | americanbankingnews.com

Q2 2023 Earnings Estimate for Aptose Biosciences Inc. Issued By Oppenheimer (TSE:APS)

March 28, 2023 | finance.yahoo.com

Aptose Biosciences to Participate in Cantor’s The Future of Oncology Virtual Symposium

March 27, 2023 | finance.yahoo.com

Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2022 Earnings Call Transcript

March 26, 2023 | americanbankingnews.com

Aptose Biosciences (TSE:APS) Stock Crosses Above 50 Day Moving Average of $0.88

March 25, 2023 | finanznachrichten.de

Aptose Biosciences, Inc.: Aptose Reports Results for the Fourth Quarter and Full Year 2022

March 21, 2023 | americanbankingnews.com

Aptose Biosciences (APS) to Release Earnings on Thursday

March 10, 2023 | finance.yahoo.com

Aptose Reports Immaterial Financial Exposure to Silicon Valley Bank

March 2, 2023 | finance.yahoo.com

Aptose Biosciences to Present at Oppenheimer 33rd Annual Healthcare Conference

December 30, 2022 | finance.yahoo.com

We Think Aptose Biosciences (TSE:APS) Needs To Drive Business Growth Carefully

December 12, 2022 | ca.finance.yahoo.com

Stocks in play: Aptose Biosciences Inc

September 27, 2022 | finance.yahoo.com

Seagen (SGEN) Inks Deal With LAVA Therapeutics for LAVA-1223

September 13, 2022 | finance.yahoo.com

Aptose Strengthens Board of Directors with Appointment of Bernd R. Seizinger, M.D., Ph.D.

See More Headlines

APS Price History

30 days | 90 days | 365 days | Advanced Chart

APS Company Calendar

Last Earnings: 3/23/2023
Today: 6/02/2023
Next Earnings (Estimated): 8/01/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: TSE:APS
CUSIP: N/A
CIK: N/A
Web: aptose.com
Phone: +1-647-4799828
Fax: N/A
Employees: 31
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: C$8.50
High Stock Price Forecast: C$12.00
Low Stock Price Forecast: C$5.00
Forecasted Upside/Downside: +762.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($0.64)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-44,020,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -96.45%
Return on Assets: -50.47%

Debt

Debt-to-Equity Ratio: 4.71
Current Ratio: 3.05
Quick Ratio: 5.41

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.36 per share
Price / Cash Flow: 1.60
Book Value: C$0.28 per share
Price / Book: 2.07

Miscellaneous

Outstanding Shares: 93,650,000
Free Float: N/A
Market Cap: C$54.32 million
Optionable: Not Optionable
Beta: 1.68

Key Executives

Dr. William G. Rice Ph.D. (Age 59)
Chairman, Pres & CEO

Mr. Gregory K. Chow CPA (Age 45)
MBA, BA, Sr. VP, CFO & Principal Accounting Officer

Mr. Ernest Kitt B.S.
M.S, VP of Devel. & Technical Operations

Dr. Stephen B. Howell (Age 73)
Chief Medical Officer

Mr. Peter Murray
Director of Clinical Devel.

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

APS Stock - Frequently Asked Questions

Should I buy or sell Aptose Biosciences stock right now?: 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aptose Biosciences in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" APS shares.
View APS analyst ratings or view top-rated stocks.
What is Aptose Biosciences' stock price forecast for 2023?: 3 brokerages have issued 1 year price targets for Aptose Biosciences' shares. Their APS share price forecasts range from C$5.00 to C$12.00. On average, they predict the company's share price to reach C$8.50 in the next twelve months. This suggests a possible upside of 1,365.5% from the stock's current price.
View analysts price targets for APS or view top-rated stocks among Wall Street analysts.
How have APS shares performed in 2023?: Aptose Biosciences' stock was trading at C$0.78 at the start of the year. Since then, APS shares have decreased by 25.6% and is now trading at C$0.58.
View the best growth stocks for 2023 here.
When is Aptose Biosciences' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our APS earnings forecast.
How were Aptose Biosciences' earnings last quarter?: Aptose Biosciences Inc. (TSE:APS) announced its quarterly earnings data on Thursday, March, 23rd. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.15).

What other stocks do shareholders of Aptose Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Aptose Biosciences investors own include Aptose Biosciences (APTO), Aurinia Pharmaceuticals (AUPH), Advanced Micro Devices (AMD), NVIDIA (NVDA), Aurora Cannabis (ACB), Adobe (ADBE), AltaGas (ALA), Aphria (APHA), Algonquin Power & Utilities (AQN) and Badger Daylighting (BAD).
What is Aptose Biosciences' stock symbol?: Aptose Biosciences trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APS."
How do I buy shares of Aptose Biosciences?: Shares of APS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Aptose Biosciences' stock price today?: One share of APS stock can currently be purchased for approximately C$0.58.
How much money does Aptose Biosciences make?: Aptose Biosciences (TSE:APS) has a market capitalization of C$54.32 million. The biotechnology company earns C$-44,020,000.00 in net income (profit) each year or C($0.64) on an earnings per share basis.
How can I contact Aptose Biosciences?: Aptose Biosciences' mailing address is 5955 Airport Rd Suite 228, MISSISSAUGA, ON L4V 1R9, Canada. The official website for the company is aptose.com. The biotechnology company can be reached via phone at +1-647-4799828.

This page (TSE:APS) was last updated on 6/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial